---

---

publishing date : 2021 - 10 - 25    crawled date : 2021 - 10 - 26   

save search

---

PagerDuty Dutonians raise $26,000 in Step Challenge for Humanity Matters by AJ Dullard
Published: 2021-10-25 (Crawled : 01:00) - pagerduty.com
PD | News | $21.05 3.54% 0.0% 1.3M |

Technology Services

| -51.58% | O: -0.24% H: 4.68% C: 3.39%

---

Five Star Bancorp Announces Quarterly Results
Published: 2021-10-25 (Crawled : 01:00) - globenewswire.com
FSBC | $21.925 -0.75% -0.75% 32K |

Finance and Insurance

| -12.17% | O: 0.95% H: 0.0% C: 0.0%
results

---

Albemarle Corporation Announces Dividend
Published: 2021-10-25 (Crawled : 00:00) - prnewswire.com
ALB | News | $114.21 1.71% 0.0% 1.7M |

Process Industries

| -53.1% | O: 0.23% H: 0.0% C: 0.0%
ema

---

Angel Pharmaceuticals Announces Approval of IND Application in China for ITK Inhibitor CPI-818
Published: 2021-10-25 (Crawled : 00:00) - prnewswire.com
CRVS | $1.53 6.25% 5.88% 140K |

Health Technology

| -67.93% | O: 0.0% H: 0.0% C: 0.0%
application china approval

---

Triumph Group Secures Boeing Interiors Business
Published: 2021-10-25 (Crawled : 00:00) - prnewswire.com
TGI | $13.32 2.54% 0.15% 570K |

Electronic Technology

| -34.72% | O: 0.35% H: 0.0% C: 0.0%

---

UCLA Anderson Forecast to Launch a Fellowship Program Focused on Developing Professional Economists from Diverse Backgrounds
Published: 2021-10-25 (Crawled : 00:00) - prnewswire.com
EIX | $70.85 0.27% 0.0% 1.7M |

Utilities

| 15.65% | O: 0.23% H: 0.0% C: 0.0%

---

Restaurant Marketing Strategies : 4 Sweet Ways To Market Your Dessert
Published: 2021-10-25 (Crawled : 00:00) - lightspeedhq.com
FNCTF | News | $11.16 -20.84% 130 |

Communications

| Email alert Add to watchlist
restaurant market

---

4D Molecular Therapeutics Reports Interim Results from the 4D-310 Phase 1/2 Clinical Trial in Patients with Fabry Disease and Provides Clinical Data Update from the 4D-110 Phase 1/2 Clinical Trial in Patients with Choroideremia
Published: 2021-10-25 (Crawled : 00:00) - biospace.com/
FDMT M | $24.77 -6.14% -6.54% 570K |

Health Technology

| -18.52% | O: 0.22% H: 2.43% C: 1.48%
disease phase 1 results molecular trial phase 2 phase 3

---

Gainers vs Losers

78%

22%

Top 10 Gainers

MTTR | News 4 | $4.6 164.37% 62.17% 28M |

AGBA | $2.94 135.2% 57.48% 66M |

Finance

EDBL | News | $6.46 71.81% 41.8% 2M |

MTC | $2.25 44.23% 30.67% 6M |

Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M |

Finance

SHIM | $3.05 35.56% 26.23% 1.1M |

HKIT | $1.345 31.86% 24.16% 390K |

Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M |

Wholesale Trade

OST | $0.512 28.0% 21.88% 290K |

POET | $1.59 27.2% 21.38% 4.2M |

Manufacturing

---

Your saved searches

---